▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3991 by analyst upside · 2026-09-28
SMTI
Sanara MedTech Inc.
Healthcare · Market Cap $322M · P/E 0x
ANALYST PRICE TARGET
-0.2%
implied upside to consensus target
Current Price $35.06
Consensus Target $35.0
Bull Target $35.0
Bear Target $35.0
Analysts Covering 3
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
0
Hold
3
Sell
0
52-Week Low $16.05
52-Week High $35.34
YTD Return +51.8%
FUNDAMENTALS
Market Cap $322M
P/E Ratio (TTM) N/A
Forward P/E 64.9x
EPS (TTM) $-0.04
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $110M
Profit Margin -29.2%
52-WEEK RANGE
52-Week Low $16.05
52-Week High $35.34
Current Price $35.06
Bear Target $35.0
Bull Target $35.0
● Now $35.06 ● Target $35.0
TRADING DATA
Avg Volume 260K
YTD Return +51.8%
Analyst Count 3
Consensus Hold
Upside to Target -0.2%
Last Updated 2026-09-28

ANALYST SUMMARY

Sanara MedTech Inc. (SMTI) is currently trading at $35.06 with a Wall Street consensus price target of $35.0, which is 0.2% below the current price over the next 12 months. 3 analysts currently cover SMTI, with a consensus rating of Hold - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $35.0, while the most cautious has a target of $35.0.

SMTI operates in the Healthcare sector with a market capitalisation of $322M. The stock is up 51.8% year-to-date and is currently trading near the upper end of its 52-week range of $16.05 – $35.34.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SMTI, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. ↓ Downgrade
Buy → Neutral 2026-07-30 31% win rate (48 calls)
Freedom Broker ● Initiated
Buy 2026-06-17 Building track record
Lake Street ● Initiated
Buy 2026-04-15 27% win rate (11 calls)
HC Wainwright & Co. reit
Buy → Buy 2026-01-26 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-11-14 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-08-18 31% win rate (48 calls)
HC Wainwright & Co. - Reiterated
Buy → Buy 2025-05-15 31% win rate (48 calls)
Cantor Fitzgerald reit
Overweight → Overweight 2025-03-26 40% win rate (10 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
21
out of 100
Coverage depth
11/30
Consensus clarity
8/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →